
Chinook Therapeutics: Best Biotech For Kidney Disease Exposure, With Catalysts (KDNY)
AsiaVision Background & KDNY’s platform technology Chinook Therapeutics, Inc. (NASDAQ:KDNY) is developing two therapies targeting IgA nephropathy that will play a key role in IgA Nephropathy. Atrasentan is an endothelin receptor antagonist, which treats IgAN […]